Business News
IDT secures funding for new gene silencing research
Published in Gene Therapy Weekly, September 24th, 2009
Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, has been awarded $99,750 from the National Institutes of Health ARRA (American Recovery and Reinvestment Act) funding to continue work on its research project 'Gene Silencing with U1 Adapter Oligonucleotides.' As a new class of synthetic nucleic acids, the U1 adapters are capable of down-regulating the expression of genes of interest at the pre-mRNA stage, via a mechanism of action distinct from antisense or siRNA. This innovative new technology is based on oligos annealing to a specific region within the 3'-terminal exon of a gene to inhibit pre-mRNA processing and subsequent gene expression and can...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2009-09-24)
More Articles from Gene Therapy Weekly
- Broad Institute of Mit and Harvard
Large-scale study probes how cells fight pathogens - Apoptosis
New apoptosis study findings have been reported from Cleveland Clinic - Apoptosis
New apoptosis study results from S. Abdelli et al described - Cancer Gene Therapy
Scientists at Gene Therapy Center describe research in cancer gene therapy - Cancer Gene Therapy
Study data from Y.H. Huang and co-authors update knowledge of cancer gene therapy - Enzyme Research
New enzyme research study findings reported from University of Calgary, Medical Department - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
